FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023409962> ?p ?o ?g. }

• W2023409962 endingPage "48" @default.
• W2023409962 startingPage "33" @default.
• W2023409962 abstract "Paclitaxel (Taxol®) is one of the best antineoplastic drugs found from nature in the past decades. Like many other anticancer drugs, there are difficulties in its clinical administration due to its poor solubility. Therefore an adjuvant called Cremophor EL has to be employed, but this has been found to cause serious side-effects. However, nanoparticles of biodegradable polymers can provide an ideal solution to the adjuvant problem and realise a controlled and targeted delivery of the drug with better efficacy and fewer side-effects. The present research proposes a novel formulation for fabrication of nanoparticles of biodegradable polymers containing d-α-tocopheryl polyethylene glycol 1000 succinate (vitamin E TPGS or TPGS) to replace the current method of clinical administration and, with further modification, to provide an innovative solution for oral chemotherapy. In the modified solvent extraction/evaporation technique employed in this research, the emulsifier/stabiliser/additive and the matrix material can play a key role in determining the morphological, physicochemical and pharmaceutical properties of the produced nanoparticles. We found that vitamin E TPGS could be a novel surfactant as well as a matrix material when blended with other biodegradable polymers. The nanoparticles composed of various formulations and manufactured under various conditions were characterised by laser light scattering (LLS) for size and size distribution, scanning electron microscopy (SEM) and atomic force microscopy (AFM) for morphological properties, X-ray photoelectron spectroscopy (XPS) for surface chemistry and differential scanning calorimetry (DSC) for thermogram properties. The drug encapsulation efficiency (EE) and the drug release kinetics under in vitro conditions were measured by high performance liquid chromatography (HPLC). It was concluded that vitamin E TPGS has great advantages for the manufacture of polymeric nanoparticles for controlled release of paclitaxel and other anti-cancer drugs. Nanoparticles of nanometer size with narrow distribution can be obtained. A drug encapsulation efficiency as high as 100% can be achieved and the release kinetics can be controlled." @default.
• W2023409962 created "2016-06-24" @default.
• W2023409962 creator A5051065845 @default.
• W2023409962 creator A5090841972 @default.
• W2023409962 date "2003-01-01" @default.
• W2023409962 modified "2023-10-15" @default.
• W2023409962 title "A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS" @default.
• W2023409962 cites W1609778927 @default.
• W2023409962 cites W1884529525 @default.
• W2023409962 cites W1976677427 @default.
• W2023409962 cites W1992470912 @default.
• W2023409962 cites W1995554009 @default.
• W2023409962 cites W1999507447 @default.
• W2023409962 cites W1999976043 @default.
• W2023409962 cites W2002414029 @default.
• W2023409962 cites W2002473279 @default.
• W2023409962 cites W2021100414 @default.
• W2023409962 cites W2021914114 @default.
• W2023409962 cites W2022097427 @default.
• W2023409962 cites W2022981155 @default.
• W2023409962 cites W2025852082 @default.
• W2023409962 cites W2037653676 @default.
• W2023409962 cites W2043782706 @default.
• W2023409962 cites W2044647958 @default.
• W2023409962 cites W2045135432 @default.
• W2023409962 cites W2051330205 @default.
• W2023409962 cites W2054177915 @default.
• W2023409962 cites W2058416686 @default.
• W2023409962 cites W2065982455 @default.
• W2023409962 cites W2066223236 @default.
• W2023409962 cites W2072758801 @default.
• W2023409962 cites W2080345216 @default.
• W2023409962 cites W2089557942 @default.
• W2023409962 cites W2099149475 @default.
• W2023409962 cites W2111812410 @default.
• W2023409962 cites W2117771496 @default.
• W2023409962 cites W255253920 @default.
• W2023409962 doi "https://doi.org/10.1016/s0168-3659(02)00320-6" @default.
• W2023409962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12490371" @default.
• W2023409962 hasPublicationYear "2003" @default.
• W2023409962 type Work @default.
• W2023409962 sameAs 2023409962 @default.
• W2023409962 citedByCount "660" @default.
• W2023409962 countsByYear W20234099622012 @default.
• W2023409962 countsByYear W20234099622013 @default.
• W2023409962 countsByYear W20234099622014 @default.
• W2023409962 countsByYear W20234099622015 @default.
• W2023409962 countsByYear W20234099622016 @default.
• W2023409962 countsByYear W20234099622017 @default.
• W2023409962 countsByYear W20234099622018 @default.
• W2023409962 countsByYear W20234099622019 @default.
• W2023409962 countsByYear W20234099622020 @default.
• W2023409962 countsByYear W20234099622021 @default.
• W2023409962 countsByYear W20234099622022 @default.
• W2023409962 countsByYear W20234099622023 @default.
• W2023409962 crossrefType "journal-article" @default.
• W2023409962 hasAuthorship W2023409962A5051065845 @default.
• W2023409962 hasAuthorship W2023409962A5090841972 @default.
• W2023409962 hasConcept C121332964 @default.
• W2023409962 hasConcept C127413603 @default.
• W2023409962 hasConcept C13965031 @default.
• W2023409962 hasConcept C155672457 @default.
• W2023409962 hasConcept C163588942 @default.
• W2023409962 hasConcept C171250308 @default.
• W2023409962 hasConcept C178790620 @default.
• W2023409962 hasConcept C185592680 @default.
• W2023409962 hasConcept C192562407 @default.
• W2023409962 hasConcept C2776964284 @default.
• W2023409962 hasConcept C2779820397 @default.
• W2023409962 hasConcept C2780165375 @default.
• W2023409962 hasConcept C39519442 @default.
• W2023409962 hasConcept C42360764 @default.
• W2023409962 hasConcept C43617362 @default.
• W2023409962 hasConcept C45211672 @default.
• W2023409962 hasConcept C521977710 @default.
• W2023409962 hasConcept C77281830 @default.
• W2023409962 hasConcept C97355855 @default.
• W2023409962 hasConceptScore W2023409962C121332964 @default.
• W2023409962 hasConceptScore W2023409962C127413603 @default.
• W2023409962 hasConceptScore W2023409962C13965031 @default.
• W2023409962 hasConceptScore W2023409962C155672457 @default.
• W2023409962 hasConceptScore W2023409962C163588942 @default.
• W2023409962 hasConceptScore W2023409962C171250308 @default.
• W2023409962 hasConceptScore W2023409962C178790620 @default.
• W2023409962 hasConceptScore W2023409962C185592680 @default.
• W2023409962 hasConceptScore W2023409962C192562407 @default.
• W2023409962 hasConceptScore W2023409962C2776964284 @default.
• W2023409962 hasConceptScore W2023409962C2779820397 @default.
• W2023409962 hasConceptScore W2023409962C2780165375 @default.
• W2023409962 hasConceptScore W2023409962C39519442 @default.
• W2023409962 hasConceptScore W2023409962C42360764 @default.
• W2023409962 hasConceptScore W2023409962C43617362 @default.
• W2023409962 hasConceptScore W2023409962C45211672 @default.
• W2023409962 hasConceptScore W2023409962C521977710 @default.
• W2023409962 hasConceptScore W2023409962C77281830 @default.
• W2023409962 hasConceptScore W2023409962C97355855 @default.
• W2023409962 hasIssue "1" @default.
• W2023409962 hasLocation W20234099621 @default.

• next